Sanjay Asthana
#32,544
Most Influential Person Now
Alzheimer's disease researcher
Sanjay Asthana's AcademicInfluence.com Rankings
Sanjay Asthanabiology Degrees
Biology
#3646
World Rank
#5540
Historical Rank
Neuroscience
#2406
World Rank
#2471
Historical Rank
Sanjay Asthanaphilosophy Degrees
Philosophy
#9969
World Rank
#13611
Historical Rank
Logic
#6945
World Rank
#8517
Historical Rank
Download Badge
Biology Philosophy
Sanjay Asthana's Degrees
- PhD Neuroscience Stanford University
Why Is Sanjay Asthana Influential?
(Suggest an Edit or Addition)According to Wikipedia, Sanjay Asthana is Chief of the Division of Geriatrics and Gerontology at the University of Wisconsin School of Medicine and Public Health, and holds the Duncan G. and Lottie H. Ballantine Endowed Chair in Geriatrics. Since 2009, Asthana has also served as Director of the Wisconsin Alzheimer's Disease Research Center.
Sanjay Asthana's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Gut microbiome alterations in Alzheimer’s disease (2017) (999)
- Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) (716)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. (2014) (455)
- Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. (2005) (439)
- Testosterone supplementation improves spatial and verbal memory in healthy older men (2001) (428)
- Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS–Cognitive and Affective Study (2015) (326)
- Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. (1999) (321)
- Hazzard's Geriatric Medicine and Gerontology (2016) (311)
- Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease. (2015) (278)
- High-dose estradiol improves cognition for women with AD (2001) (264)
- Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment (2005) (258)
- Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer’s disease: results of a placebo-controlled, double-blind, pilot study (1999) (257)
- Insulin dose–response effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: interactions with apolipoprotein E genotype (2003) (255)
- Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment (2006) (228)
- Insulin increases CSF Aβ42 levels in normal older adults (2003) (220)
- Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. (2005) (214)
- Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology (2016) (201)
- Four distinct trajectories of tau deposition identified in Alzheimer’s disease (2021) (200)
- Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone: A Preliminary Study (2005) (195)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
- The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease (2018) (188)
- Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's Disease: a cross-sectional study (2006) (185)
- Insulin resistance predicts brain amyloid deposition in late middle-aged adults (2015) (183)
- Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype (2000) (182)
- Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults (2013) (175)
- Physical activity attenuates age-related biomarker alterations in preclinical AD (2014) (168)
- Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults (2015) (167)
- Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE (2015) (161)
- Insulin Metabolism in Alzheimer’s Disease Differs According to Apolipoprotein E Genotype and Gender (1999) (160)
- Amyloid burden and neural function in people at risk for Alzheimer's Disease (2014) (157)
- The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions (2017) (151)
- Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative (2016) (145)
- Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults (2017) (143)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (136)
- The Influence of Alzheimer Disease Family History and Apolipoprotein E ε4 on Mesial Temporal Lobe Activation (2006) (132)
- Insulin increases CSF Abeta42 levels in normal older adults. (2003) (122)
- Magnetic Resonance Imaging Characterization of Brain Structure and Function in Mild Cognitive Impairment: A Review (2008) (120)
- Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation (2014) (120)
- Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease (2017) (119)
- Anosognosia in mild cognitive impairment: Relationship to activation of cortical midline structures involved in self-appraisal (2007) (117)
- Low cerebral blood flow is associated with lower memory function in metabolic syndrome (2012) (117)
- White matter is altered with parental family history of Alzheimer's disease (2010) (114)
- The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ɛ3/ɛ3 genotype (2011) (110)
- Low-cost transitional care with nurse managers making mostly phone contact with patients cut rehospitalization at a VA hospital. (2012) (109)
- Neurobiological Underpinnings of the Estrogen - Mood Relationship. (2012) (106)
- Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases (2012) (104)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (96)
- Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-age adults at risk of AD (2015) (93)
- The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. (2006) (93)
- Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease. (2008) (93)
- Differential modulation of plasma β-amyloid by insulin in patients with Alzheimer disease (2006) (90)
- Effect of parental family history of Alzheimer's disease on serial position profiles (2008) (89)
- Microstructural white matter alterations in preclinical Alzheimer’s disease detected using free water elimination diffusion tensor imaging (2017) (88)
- Estrogen and Alzheimer’s Disease (2002) (88)
- CSF T-Tau/Aβ42 Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer’s Disease (2012) (88)
- Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease. (2016) (88)
- Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. (2020) (86)
- A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women. (2008) (86)
- The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory. (2008) (82)
- Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease. (2014) (82)
- Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease. (2016) (80)
- Occupational Complexity and Cognitive Reserve in a Middle-Aged Cohort at Risk for Alzheimer's Disease. (2015) (80)
- Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial. (2011) (80)
- Plasma amyloid β protein is elevated in late-onset Alzheimer disease families (2008) (78)
- Cardiorespiratory fitness is associated with brain structure, cognition, and mood in a middle-aged cohort at risk for Alzheimer’s disease (2014) (78)
- Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults (2010) (75)
- Non-coding variability at the APOE locus contributes to the Alzheimer’s risk (2019) (74)
- Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age (2019) (74)
- Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease. (2015) (74)
- Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease (2006) (70)
- Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS cognitive and affective sub study (KEEPS Cog) (2013) (70)
- Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns (2017) (69)
- Effects of hormone therapy on cognition and mood. (2014) (67)
- Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease. (2015) (67)
- Potential Role of Muscarinic Agonists in Alzheimer’s Disease (1997) (66)
- Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy (2008) (65)
- Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers (2017) (65)
- Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage. (2018) (64)
- Measuring longitudinal cognition: Individual tests versus composites (2018) (63)
- Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease (1996) (62)
- Midlife predictors of Alzheimer's disease. (2010) (60)
- Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans (2012) (59)
- Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease (2017) (58)
- Clinical Pharmacology and Differential Cognitive Efficacy of Estrogen Preparations (2005) (57)
- fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: Risk factors for Alzheimer's disease (2008) (57)
- ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes (2019) (56)
- The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial. (2012) (56)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (56)
- Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers. (2015) (55)
- Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families. (2008) (55)
- Relationship between testosterone supplementation and insulin-like growth factor-I levels and cognition in healthy older men (2004) (54)
- The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? (2019) (54)
- An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum (2020) (53)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (52)
- Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study (2016) (52)
- Association of Neighborhood-Level Disadvantage With Cerebral and Hippocampal Volume. (2020) (51)
- Effects of long-term testosterone administration on cognition in older men with low or low-to-normal testosterone concentrations: a prespecified secondary analysis of data from the randomised, double-blind, placebo-controlled TEAAM trial. (2016) (51)
- Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease (2014) (51)
- Medial prefrontal functional connectivity—Relation to memory self-appraisal accuracy in older adults with and without memory disorders (2012) (50)
- Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images (2018) (49)
- Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial (2018) (48)
- Neuroprotective effects of female sex steroids in humans: current controversies and future directions. (2005) (48)
- Amyloid duration is associated with preclinical cognitive decline and tau PET (2019) (47)
- Cortical Microstructural Alterations in Mild Cognitive Impairment and Alzheimer's Disease Dementia. (2019) (47)
- Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease (2018) (47)
- BDNF Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer's Prevention (2017) (47)
- Characterization of Vascular Disease Risk in Postmenopausal Women and Its Association with Cognitive Performance (2013) (46)
- Age-dependent differences in brain tissue microstructure assessed with neurite orientation dispersion and density imaging (2016) (45)
- Association between enrollment factors and incident cognitive impairment in Blacks and Whites: Data from the Alzheimer's Disease Center (2019) (45)
- Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease. (2016) (44)
- Structural MRI discriminates individuals with Mild Cognitive Impairment from age-matched controls: A combined neuropsychological and voxel based morphometry study (2006) (44)
- Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults. (2016) (44)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (44)
- Mild Cognitive Impairment in Late Middle Age in the Wisconsin Registry for Alzheimer's Prevention Study: Prevalence and Characteristics Using Robust and Standard Neuropsychological Normative Data. (2016) (44)
- Cardiorespiratory Fitness Attenuates the Influence of Amyloid on Cognition (2015) (43)
- Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults (2012) (43)
- Associative Learning Over Trials Activates the Hippocampus in Healthy Elderly but not Mild Cognitive Impairment (2008) (42)
- Relationships between cardiorespiratory fitness, hippocampal volume, and episodic memory in a population at risk for Alzheimer's disease (2017) (42)
- Vitamin E and memantine in Alzheimer's disease: Clinical trial methods and baseline data (2014) (42)
- Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation (2015) (41)
- Effects of hormone therapy on brain structure (2016) (40)
- Age-accelerated cognitive decline in asymptomatic adults with CSF β-amyloid (2017) (40)
- Participation in cognitively-stimulating activities is associated with brain structure and cognitive function in preclinical Alzheimer’s disease (2015) (38)
- Differential Response to the Cholinergic Agonist Arecoline among Different Cognitive Modalities in Alzheimer’s Disease (1996) (37)
- Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer’s Disease (2018) (37)
- Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease (2017) (36)
- Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing (2018) (36)
- Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of AD (2017) (36)
- Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia (2018) (35)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (35)
- KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD (2019) (35)
- In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease (2021) (35)
- Hypertension and obesity moderate the relationship between β-amyloid and cognitive decline in midlife (2018) (35)
- Hormone effects on fMRI and cognitive measures of encoding: Importance of hormone preparation (2006) (35)
- Masculine vitality: pros and cons of testosterone in treating the andropause. (2004) (33)
- Insulin resistance is associated with lower arterial blood flow and reduced cortical perfusion in cognitively asymptomatic middle-aged adults (2017) (33)
- Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife. (2016) (33)
- Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults. (2007) (32)
- Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer’s disease in late-middle-aged adults (2019) (32)
- Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease (2005) (31)
- Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention (2014) (30)
- Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease. (2017) (30)
- 17β-Estradiol Reduces Plasma Aβ40 for HRT-Naïve Postmenopausal Women With Alzheimer Disease: A Preliminary Study (2003) (29)
- Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer's disease (2017) (29)
- The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease (2018) (29)
- Effects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type. (1991) (29)
- Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits (2016) (28)
- The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition. (2014) (28)
- Meeting physical activity recommendations may be protective against temporal lobe atrophy in older adults at risk for Alzheimer's disease (2016) (28)
- DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer's Disease. (2018) (27)
- Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis (2018) (27)
- Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau (2020) (26)
- Awareness of Memory Abilities in Community-Dwelling Older Adults with Suspected Dementia and Mild Cognitive Impairment (2010) (26)
- Label‐free quantitative comparison of cerebrospinal fluid glycoproteins and endogenous peptides in subjects with Alzheimer's disease, mild cognitive impairment, and healthy individuals (2016) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? (2019) (26)
- Estrogen and cognition: the story so far. (2003) (25)
- Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease (2021) (25)
- Intracranial arterial four-dimensional flow is associated with metrics of brain health and Alzheimer's disease (2015) (25)
- The Area Deprivation Index: A novel tool for harmonizable risk assessment in Alzheimer's disease research (2020) (24)
- Frontiers proposal. National Institute on Aging “bench to bedside: estrogen as a case study” (2009) (24)
- Effects of insulin and octreotide on memory and growth hormone in Alzheimer's disease. (2009) (24)
- A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele (2008) (24)
- The Wisconsin Registry for Alzheimer’s Prevention: A Review of findings and current directions (2017) (24)
- Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease. (2009) (23)
- Differential effects of neurodegeneration biomarkers on subclinical cognitive decline (2019) (23)
- Cognitive response to estradiol in postmenopausal women is modified by high cortisol (2012) (23)
- Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum (2019) (23)
- Amyloid Burden, Neuronal Function, and Cognitive Decline in Middle-Aged Adults at Risk for Alzheimer's Disease (2014) (22)
- Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker. (2017) (22)
- 18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery (2018) (21)
- A Pilot Study of Perceived Mouth Dryness, Perceived Swallowing Effort, and Saliva Substitute Effects in Healthy Adults Across the Age Range (2018) (21)
- Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative (2016) (21)
- Neuroendocrine responses to intravenous infusion of arecoline in patients with Alzheimer's disease (1995) (21)
- Effects of acute infusion of the muscarinic cholinergic agonist arecoline on verbal memory and visuo-spatial function in dementia of the alzheimer type (1991) (20)
- Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (20)
- KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease (2021) (19)
- Effects of atorvastatin on cerebral blood flow in middle-aged adults at risk for Alzheimer's disease: a pilot study. (2012) (19)
- Treatment of Alzheimer Disease by Continuous Intravenous Infusion of Physostigmine (1995) (19)
- A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data (2019) (19)
- Impact of Cognitive Impairment Across Specialties: Summary of a Report From the U13 Conference Series (2019) (18)
- Differential effects of hormone therapy on serotonin, vascular function and mood in the KEEPS (2016) (18)
- Fitness, independent of physical activity is associated with cerebral blood flow in adults at risk for Alzheimer’s disease (2019) (17)
- Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations (2020) (17)
- Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status (2021) (16)
- Effects of testosterone administration on cognitive function in hysterectomized women with low testosterone levels: a dose–response randomized trial (2015) (16)
- Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways (2016) (16)
- Neuropsychiatric symptoms in dementia. (2019) (16)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (15)
- Elevated Insulin and Insulin Resistance are Associated with Altered Myelin in Cognitively Unimpaired Middle‐Aged Adults (2019) (15)
- Estrogen and Cognition: A True Relationship? (2004) (15)
- Cardiorespiratory fitness attenuates age-associated aggregation of white matter hyperintensities in an at-risk cohort (2018) (14)
- NSAIDs May Protect Against Age-Related Brain Atrophy (2010) (14)
- Longitudinal Assessment of Self- and Informant-Subjective Cognitive Complaints in a Sample of Healthy Late-Middle Aged Adults Enriched with a Family History of Alzheimer’s Disease (2017) (14)
- Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user bias. (2009) (13)
- Measuring informed consent capacity in an Alzheimer's disease clinical trial (2016) (13)
- Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention (2015) (13)
- Association of Neighborhood Context, Cognitive Decline, and Cortical Change in an Unimpaired Cohort (2021) (12)
- Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study (2021) (12)
- Alzheimer’s disease: the impact of age-related changes in reproductive hormones (2005) (12)
- Neuropsychiatric Symptoms and Caregiver Burden in Individuals With Alzheimer’s Disease: The TEAM-AD VA Cooperative Study (2018) (12)
- A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease (2016) (12)
- Neuroendocrine responses to intravenous infusion of physostigmine in patients with Alzheimer disease. (1999) (11)
- Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity. (2017) (11)
- Factors Associated with Lumbar Puncture Participation in Alzheimer’s Disease Research (2020) (11)
- The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum (2016) (10)
- Association of Cardiovascular and Alzheimer's Disease Risk Factors with Intracranial Arterial Blood Flow in Whites and African Americans. (2019) (10)
- Association of Cardiovascular Risk Factors with Cerebral Perfusion in Whites and African Americans. (2020) (10)
- Age-Related Tau Burden and Cognitive Deficits Are Attenuated in KLOTHO KL-VS Heterozygotes. (2021) (10)
- Family history and TOMM40 ‘523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts (2017) (10)
- Pilot Test of a Computer-Based System to Help Family Caregivers of Dementia Patients. (2019) (10)
- FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2020) (9)
- Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease (2022) (9)
- Effects of Simvastatin on Augmentation Index Are Transient: Outcomes From a Randomized Controlled Trial (2019) (9)
- Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease (2021) (9)
- Impact of sex and APOE ε4 on age-related cerebral perfusion trajectories in cognitively asymptomatic middle-aged and older adults: A longitudinal study (2021) (9)
- Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts (2021) (8)
- Interaction of amyloid and tau on cortical microstructure in cognitively unimpaired adults (2021) (8)
- IMAGING OF TAU PATHOLOGY IN PATIENTS WITH NON-ALZHEIMER'S DISEASE TAUOPATHIES BY [11C]PBB3-PET (2014) (8)
- A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease (2020) (8)
- Effects of hormone therapy on brain structure A randomized controlled trial (8)
- Gut microbiome alterations in Alzheimer’s disease (2017) (8)
- A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease (2022) (7)
- Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization (2021) (7)
- Latent Factor Structure and Measurement Invariance of the NIH Toolbox Cognition Battery in an Alzheimer’s Disease Research Sample (2020) (7)
- 17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study. (2003) (7)
- CSF AND PLASMA LEVELS OF INFLAMMATION DIFFERENTIALLY RELATE TO CNS MARKERS OF ALZHEIMER'S DISEASE PATHOLOGY AND NEURONAL DAMAGE (2017) (7)
- LATENT FACTOR STRUCTURE AND MEASUREMENT INVARIANCE OF THE NIH TOOLBOX COGNITION BATTERY IN A SAMPLE FROM THE WISCONSIN ALZHEIMER’S DISEASE RESEARCH CENTER (2018) (6)
- Does Rural Living in Early Life Increase the Risk for Reduced Cognitive Functioning in Later Life? (2021) (6)
- Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume (2022) (6)
- Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease (2022) (6)
- In-Depth Site-Specific O-Glycosylation Analysis of Glycoproteins and Endogenous Peptides in Cerebrospinal Fluid (CSF) from Healthy Individuals, Mild Cognitive Impairment (MCI), and Alzheimer's Disease (AD) Patients. (2021) (6)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (6)
- Apathy in Preclinical Alzheimer’s Disease: Psychometric Validation of the Apathy Evaluation Scale (2018) (6)
- Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease (2018) (6)
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2018) (6)
- Atorvastatin Therapy is Associated with Greater and Faster Cerebral Hemodynamic Response (2008) (5)
- P3-012 Effects of rosiglitazone treatment on serum amyloid-beta 1–40 and 1–42 in patients with early Alzheimer's disease (2004) (5)
- The Influence of AD Family History and APOE 4 on Mesial Temporal Lobe Activation (2009) (5)
- Dementia Trends in the United States: Read Up and Weigh In. (2017) (5)
- An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease (2022) (5)
- O4-05-05 Rosiglitazone preserves cognitive functions in patients with early Alzheimer's disease (2004) (5)
- Inflammation, tau pathology, and synaptic integrity associated with sleep spindles and memory prior to β-amyloid positivity. (2022) (5)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (5)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (4)
- Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 (2022) (4)
- Cigarette Smoking Status, Cigarette Exposure, and Duration of Abstinence Predicting Incident Dementia and Death: A Multistate Model Approach. (2021) (4)
- A randomized, double-blind placebo-controlled trial of simvastatin on CSF, MRI, and cognitive biomarkers in middle-aged adults at risk for Alzheimer's disease: The ESPRIT Study (2010) (4)
- Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age (2021) (4)
- SUBJECTIVE MEMORY COMPLAINTS, CORTICAL THINNING, AND COGNITIVE DYSFUNCTION IN MIDDLE-AGED ADULTS AT RISK FOR AD: FINDINGS FROM THE WISCONSIN REGISTRY FOR ALZHEIMER'S PREVENTION (2014) (4)
- Crosswalk study on blood collection‐tube types for Alzheimer's disease biomarkers (2022) (4)
- Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients (2022) (4)
- LUMBAR PUNCTURE SIDE EFFECT RATES IN A RESEARCH SETTING (2018) (4)
- OCCUPATIONAL COMPLEXITY, COGNITIVE RESERVE, AND WHITE MATTER HYPERINTENSITIES: FINDINGS FROM THE WISCONSIN REGISTRY FOR ALZHEIMER'S PREVENTION (2016) (3)
- Effects of simvastatin on white matter integrity in healthy middle‐aged adults (2021) (3)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (3)
- CHARACTERIZING STRUCTURAL BRAIN ALTERATIONS IN ALZHEIMER’S DISEASE PATIENTS WITH MACHINE LEARNING (2018) (3)
- Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment (2022) (3)
- Principal components from untargeted cerebrospinal fluid metabolomics associated with Alzheimer's disease biomarkers (2022) (3)
- Effects of insulin on cerebrospinal fluid levels of Aβ42 (2000) (3)
- Cardiorespiratory Fitness Modifies Influence of Sleep Problems on Cerebrospinal Fluid Biomarkers in an At-Risk Cohort. (2019) (3)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (3)
- Informed Consent in Two Alzheimer’s Disease Research Centers: Insights From Research Coordinators (2020) (3)
- GUT MICROBIOME ALTERATIONS IN ALZHEIMER'S DISEASE AND THE RELATIONSHIP WITH CSF BIOMARKERS (2017) (3)
- NEIGHBORHOOD DISADVANTAGE PREDICTS HIPPOCAMPAL VOLUME AMONG PARTICIPANTS IN THE WISCONSIN REGISTRY FOR ALZHEIMER’S PREVENTION (2018) (3)
- Posteromedial hyperactivation during episodic recognition among people with memory decline: findings from the WRAP study (2015) (3)
- Estrogen, Cognition, and Dementia (2005) (3)
- Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults (2021) (3)
- Liver-specific polygenic risk score is more strongly associated than genome-wide score with Alzheimer's disease diagnosis in a case-control analysis (2021) (3)
- Large-scale proteome analysis of CSF implicates altered glucose metabolism in Alzheimer's disease (2021) (2)
- Early detection of cognitive decline in high functioning older adults (2000) (2)
- TRANSFORMATION OF CSF BIOMARKER VALUES BETWEEN MEASUREMENT BATCHES (2018) (2)
- Cardiorespiratory Fitness Associates with Cerebral Vessel Pulsatility in a Cohort Enriched with Risk for Alzheimer’s Disease (2020) (2)
- Assessing Dementia Prevalence in the Wisconsin Longitudinal Study: Cohort Profile, Protocol, and Preliminary Findings. (2021) (2)
- TOMM40 Variable Length Polymorphism is Associated With Memory Function in Asymptomatic Middle-aged Persons (2010) (2)
- Alzheimer's disease biomarker-based clusters predict amyloid accumulation and cognitive decline in a preclinical cohort: Findings from the wisconsin registry for Alzheimer’s prevention (WRAP) (2015) (2)
- Depression symptoms associated with cognitive impairment: Is it really depression? (2000) (2)
- O2-02-06 Insulin effects on plasma beta-amyloid levels in normal adults and patients with AD (2004) (2)
- Positive affect predicts cerebral glucose metabolism in late middle-aged adults (2017) (2)
- CSF sphingomyelin metabolites in Alzheimer’s disease, neurodegeneration, and neuroinflammation (2021) (2)
- Tomm40 is Associated with Gray Matter Volume in Middle-aged Persons with Apoe ɛ3/ɛ3 Genotype (2010) (2)
- LONGITUDINAL CSF BIOMARKER CHANGES IN MIDDLE-AGED ADULTS AT RISK FOR AD: THE WISCONSIN REGISTRY FOR ALZHEIMER’S PREVENTION (WRAP) AND WISCONSIN ADRC COHORTS (2017) (2)
- Alterations in myelin content are related to cognitive performance in nondemented older adults: Findings from the wisconsin registry for Alzheimer’s prevention study (2015) (1)
- Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease. (2017) (1)
- Principal components from untargeted CSF metabolomics associated with tau (2020) (1)
- Incident MCI and dementia in Hispanic and non‐Hispanic whites: Implications for ethnic comparisons of risk in Alzheimer’s Disease Center data (2020) (1)
- Amyloid time: Quantifying the onset of abnormal biomarkers and cognitive impairment along the Alzheimer’s disease continuum (2021) (1)
- Cerebrospinal fl uid sphingolipids , b-amyloid , and tau in adults at risk for Alzheimer ’ s disease (2014) (1)
- P1-391 Potential of soy isoflavones to treat age-associated cognitive declines (2004) (1)
- Diet and APOE as moderators of the relationship between trimethylamine N‐oxide and biomarkers of Alzheimer's disease and glial activation (2021) (1)
- Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2021) (1)
- Update on Diagnosis and Treatment of Alzheimer Disease (2005) (1)
- Circulating Klotho Is Higher in Cerebrospinal Fluid than Serum and Elevated Among KLOTHO Heterozygotes in a Cohort with Risk for Alzheimer's Disease. (2022) (1)
- High amyloid load is associated with episodic memory decline and incident mild cognitive impairment in middle-aged adults in the wisconsin registry for Alzheimer’s prevention (WRAP) (2015) (1)
- Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations (2021) (1)
- Cardiorespiratory capacity modifies the association between a polygenic risk score and CSF biomarkers in preclinical Alzheimer’s disease (2015) (1)
- Measurement batch differences and between‐batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values (2021) (1)
- MK‐6240 imaging features, cognitive associations in preclinical Alzheimer’s disease and a case with imaging‐to‐postmortem correlates (2020) (1)
- COHORT AND RACE DIFFERENCES IN FACTORS ASSOCIATED WITH ATTRITION IN LONGITUDINAL STUDIES OF ALZHEIMER’S DISEASE (2017) (1)
- Alzheimer's disease biomarker-based clusters predict amyloid accumulation and cognitive decline in a preclinical cohort: Findings from the wisconsin registry for Alzheimer's prevention (WRAP) (2015) (1)
- EFFECTIVE CONNECTIVITY WITHIN THE LEFT AND RIGHT EXECUTIVE CONTROL NETWORKS IN MCI AND AD (2019) (1)
- A NOVEL PARTICIPANT-CENTERED APPROACH TO RETENTION: THE WISCONSIN ADRC RENTENTION PROGRAM (2017) (1)
- Effects of hormone therapy on brain structure in recently postmenopausal women: A randomized controlled trial (2015) (1)
- CSF NFL levels and neuroimaging‐derived neurite density index improve prediction of MCI and dementia clinical diagnosis within the Alzheimer’s pathologic framework (2020) (1)
- MODERATE INTENSITY PHYSICAL ACTIVITY ASSOCIATES WITH CSF BIOMARKERS IN PRECLINICAL ALZHEIMER’S DISEASE (2017) (1)
- P1-255 Cortisol infusion attenuates insulin's facilitation of verbal memory in patients with Alzheimer's disease (2004) (1)
- Protective genetic variants in the MS4A gene cluster modulate microglial activity (2020) (1)
- The Interaction between Ventricle to Brain Ratio and Serum Klotho on Cognition in Older Adults at Risk for Alzheimer’s Disease (2021) (1)
- Age-related differences in white matter microstructure measured by advanced diffusion MRI in healthy older adults at risk for Alzheimer’s disease (2022) (1)
- CSF sphingolipids, β -amyloid, and tau in adults at risk for Alzheimer's disease (2014) (1)
- Cognitive decline, neural function and amyloid burden in middle-aged adults at risk for Alzheimer’s disease: Findings from the Wisconsin Registry for Alzheimer's Prevention (2013) (1)
- THE WRAP-AROUND APPROACH: A NOVEL RENTENTION STRATEGY IN THE AA-FAIM STUDY (2017) (1)
- P4-402: Baseline cognitive and demographic characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS) (2008) (1)
- CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status (2021) (1)
- Hormones, Cognition and Dementia: The use of transdermal 17β-estradiol in the treatment of Alzheimer's disease (2009) (1)
- Insulin and cortisol effects of memory in Alzheimer's disease (2000) (1)
- The relationship of glucose-stimulated insulin secretion to cerebral glucose metabolism and cognition in healthy middle-aged and older adults (2021) (1)
- Increased adiposity is related to reduced neurite complexity in the hippocampus, fornix, and uncinate fasciculus of cognitively unimpaired adults (2021) (1)
- OCCUPATIONAL COMPLEXITY, COGNITIVE RESERVE, AND WHITE MATTER HYPERINTENSITIES: FINDINGS FROM THE WISCONSIN REGISTRY FOR ALZHEIMER'S PREVENTION (2016) (1)
- Age-Related Tau Burden and Cognitive Deficits Are Attenuated in KLOTHO KL-VS Heterozygotes. (2021) (1)
- ApoE-e4 is associated with altered myelin content in preclinical ad (2015) (1)
- Midlife insulin resistance is associated with hypometabolism on FDG-PET (2013) (1)
- PATTERNS OF [C-11]PIB AMYLOID BURDEN THAT ARE ASSOCIATED WITH CEREBROSPINAL FLUID AD BIOMARKERS IN PEOPLE AT RISK FOR ALZHEIMER'S DISEASE: FINDINGS FROM THE WRAP STUDY (2014) (1)
- A MEDIATION ANALYSIS OF THE RELATIONSHIP BETWEEN WHITE MATTER HYPERINTENSITIES, CSF BIOMARKERS, AND COGNITION IN COGNITIVELY UNIMPAIRED AND IMPAIRED ADULTS (2019) (1)
- Role of oestrogen in the treatment and prevention of Alzheimer's disease. (1997) (1)
- Raloxifene: Cognitive-enhancing effects for postmenopausal women with AD (2000) (1)
- Neighborhood disadvantage is associated with accelerated cortical thinning and cognitive decline in cognitively unimpaired adults (2020) (1)
- CSF metabolites associated with CSF NeuroToolKit biomarkers (2021) (1)
- SUBJECTIVE MEMORY COMPLAINTS, CORTICAL THINNING, AND COGNITIVE DYSFUNCTION IN MIDDLE-AGED ADULTS AT RISK FOR AD: FINDINGS FROM THE WISCONSIN REGISTRY FOR ALZHEIMER'S PREVENTION (2014) (1)
- PRELIMINARY FINDINGS FROM AN ONGOING LONGITUDINAL METABOLOME-WIDE ASSOCIATION STUDY OF COGNITIVE DECLINE IN HEALTHY ADULTS WITH INCREASED RISK FOR ALZHEIMER’S DISEASE (2017) (0)
- EFFECTS OF KIBRA POLYMORPHISM ON WHITE MATTER INTEGRITY: FINDINGS FROM THE WISCONSIN REGISTRY FOR ALZHEIMER’S PREVENTION (2016) (0)
- Antecedent biomarkers of presymptomatic stages of Alzheimer?s disease: Results from the Wisconsin Alzheimer?s Disease Research Center (ADRC) and other studies (2014) (0)
- A COMPARISON OF METHODS TO MEASURE INTRA-INDIVIDUAL COGNITIVE VARIABILITY IN NON-HISPANIC WHITES AND AFRICAN AMERICANS IN THE WISCONSIN REGISTRY FOR ALZHEIMER'S PREVENTION (WRAP) (2017) (0)
- NEUROFILAMENT LIGHT PROTEIN IS ASSOCIATED WITH COGNITIVE DECLINE WITHIN THE ATN MODEL (2018) (0)
- EXAMINING THE ROLE OF CIGARETTE SMOKING AND CESSATION ON COMBINED RISK OF INCIDENT DEMENTIA, NURSING HOME PLACEMENT, AND DEATH IN COGNITIVELY HEALTHY AND MILD COGNITIVELY IMPAIRED ADULTS (2019) (0)
- CSF sphingomyelin metabolites in Alzheimer's disease, neurodegeneration, and neuroinflammation (2022) (0)
- USING AN ABBREVIATED CAIDE RISK SCORE TO PREDICT BRAIN AMYLOID ACCUMULATION (2019) (0)
- P2-276: Lumbar puncture procedures are not a barrier to recruitment into clinical trials for Alzheimer's disease prevention (2008) (0)
- DEVELOPING AN ELECTRONIC CONSENT FOR ADRC HIGH COMPLIANCE, CONTINUOUS LONG-TERM HOME MONITORING OF SLEEP ACTIVITY IN DIVERSE POPULATIONS DIFFERENTIATES LOWER COGNITIVE FUNCTIONING OLDER ADULTS (2019) (0)
- THE ASSOCIATION OF DEPRESSIVE SYMPTOMS, APATHY, AND ANTIDEPRESSANT USE WITH INCIDENT MCI AND DEMENTIA IN THE NACC DATASET (2018) (0)
- HYPOXIA DURING SLEEP IS ASSOCIATED WITH HIPPOCAMPAL VOLUME IN COGNITIVELY UNIMPAIRED ADULTS (2018) (0)
- DEVELOPING AN ELECTRONIC CONSENT FOR ADRC (2019) (0)
- EFFECTS OF KIBRA POLYMORPHISM ON WHITE MATTER INTEGRITY: FINDINGS FROM THE WISCONSIN REGISTRY FOR ALZHEIMER’S PREVENTION (2016) (0)
- IC-P-088 Reduced medial parietal activity in cognitively healthy middle-aged individuals with a parental history of Alzheimer’s disease (2006) (0)
- The evolution of geriatric neurology. (2019) (0)
- P-113 4 point clock drawing task is superior to the Mini Mental Status Exam for detection of cognitive impairment in community memory screenings (2007) (0)
- STRESS IS ASSOCIATED WITH GREATER INSULIN RESISTANCE, HIGHER CSF PHOSPHORYLATED TAU, AND DECREASED GLUCOSE METABOLISM IN THE MEDIAL TEMPORAL LOBE IN APOE Ε4 CARRIERS (2016) (0)
- Racine – Construct and convergent validity of CogState in late middle-age (2017) (0)
- Relationship Between TOMM40 and APOE Genotypes in the Wisconsin Registry for Alzheimer’s Prevention (WRAP) (2011) (0)
- NEIGHBORHOOD DISADVANTAGE IS ASSOCIATED WITH NEUROPATHOLOGICALLY CONFIRMED ALZHEIMER’S DISEASE (2019) (0)
- THE ATN FRAMEWORK AND POLYGENIC SCORES OF AD ENDOPHENOTYPES (2019) (0)
- The relationship of cerebral perfusion with age and CSF measures in middle-aged adults at risk for Alzheimer's disease (2013) (0)
- EFFECTIVE CONNECTIVITY WITHIN THE DEFAULT MODE NETWORK IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE (2018) (0)
- Antemortem‐postmortem correlates of 4D‐Flow MRI in cerebral vessels (2022) (0)
- CSF neurofilament light proteins and cognitive performance in middle-aged adults at increased risk for Alzheimer's disease (2012) (0)
- Baseline lipid levels predict cerebral blood flow response to statin therapy in middle-aged adults at risk for Alzheimer's disease (2013) (0)
- P2-352 Alzheimer's disease: potential beneficial effects of estrogen on performance-based battery of physical function skills for older women (2004) (0)
- O1-04-07 CSF and MRI perfusion biomarkers in middle-aged adults at risk for Alzheimer’s disease: Influence of APOE4 allele (2007) (0)
- IC-P2-157: fMRI activation in medial temporal lobe correlates with monthly decline rate of memory function in mild cognitive impairment patients (2008) (0)
- PHYSICAL ACTIVITY MODIFIES ALZHEIMER BIOMARKERS IN PRECLINICAL AD: EVIDENCE FROM THE WISCONSIN REGISTRY FOR ALZHEIMER'S PREVENTION (2014) (0)
- Metabolic syndrome in middle-aged adults is associated with brain perfusion deficits (2012) (0)
- Hormone therapy use and risk factors for Alzheimer's disease: Data from the Wisconsin Registry for Alzheimer's Prevention (2009) (0)
- Hormones, Cognition and Dementia: Alternative estrogenic treatment regimens and the Kronos Early Estrogen Prevention Study – Cognitive and Affective substudy (KEEPS-CA) (2009) (0)
- NEURODEGENERATION, AMYLOID, AND LONGITUDINAL VERBAL LEARNING AND MEMORY PERFORMANCE (2018) (0)
- LOWER ARTERIAL BLOOD FLOW AND HIGHER PULSATILITY INDEX ARE ASSOCIATED WITH NEURONAL INJURY (2019) (0)
- Mid-life dementia risk scores as a predictor of CSF biomarker response to simvastatin therapy in asymptomatic adults at risk for Alzheimer's disease: The ESPRIT study (2010) (0)
- Amyloid pathology is associated with extensive myelin alteration in preclinical Alzheimer’s disease: New insights into disease process with novel brain imaging (2015) (0)
- White matter cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease (2013) (0)
- Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states (2018) (0)
- The Wisconsin Alzheimer's Institute Dementia Diagnostic Clinic Network: A community of practice to improve dementia care (2022) (0)
- LONGEVITY GENE KLOTHO ALTERS APOE4-RELATED CORTICAL THINNING: FINDINGS FROM THE WISCONSIN REGISTRY FOR ALZHEIMER’S PREVENTION (2016) (0)
- A COMPARISON OF MULTI-TEST OPERATIONALIZATIONS OF COGNITIVE DECLINE USING LONGITUDINAL NORMS: ASSOCIATIONS WITH PROGRESSION TO COGNITIVE IMPAIRMENT AND AMYLOID STATUS (2018) (0)
- 38 CSF METABOLITES ARE HIGHLY PREDICTIVE OF CSF TOTAL TAU AND PHOSPHORYLATED TAU (2019) (0)
- AMERICAN INDIAN RESEARCH OF COGNITION (ARC): THE IMPACT OF RACIAL DIFFERENCES ON CEREBROVASCULAR RISK FACTORS, COGNITIVE PERFORMANCE AND WHITE MATTER LESION BURDEN (2019) (0)
- Longitudinal changes in left anterior hippocampal activation in cognitively normal subjects with APOE ɛ4 polymorphism (2011) (0)
- P1-344 POOR SLEEP QUALITY IS ASSOCIATEDWITH CSF MARKERS OFAMYLOID DEPOSITION IN COGNITIVELY HEALTHYADULTS AT RISK FOR ALZHEIMER’S DISEASE (2019) (0)
- P4-305 IMPACT OF SIMVASTATIN ON CEREBRAL BLOOD FLOW, PULSATILITY INDEX, AND ALZHEIMER’S DISEASE BIOMARKERS: A CLINICALTRIAL (0)
- O2-04-04 Associations of bold fMRI and arterial spin labeling perfusion imaging with atorvastatin therapy in a group of middle-aged adults at high risk of developing AD (2007) (0)
- INCREASED PLASMA TRIMETHYLAMINE-N-OXIDE (TMAO) IS ASSOCIATED WITH LOWER HIPPOCAMPAL BLOOD FLOW (2018) (0)
- 0282 WHITE MATTER DAMAGE AND AXONAL DEGENERATION ARE RELATED TO HYPOXIA IN UNTREATED OBSTRUCTIVE SLEEP APNEA (2017) (0)
- Association of cognitive health status with happiness, helplessness and hopelessness in different races (2020) (0)
- P3-062: Relationship of atherogenic lipid profiles and gender with CSF biomarkers in middle-aged adults at risk for Alzheimer's disease (2008) (0)
- Antemortem‐postmortem correlates of 4D‐Flow MRI in cerebral vessels (2022) (0)
- CSF BIOMARKER PROFILES IN MIDDLE-AGED ADULTS WITH PARENTAL HISTORY OF AD: THE WISCONSIN ADRC COHORTS (2014) (0)
- Insulin Homeostasis Mediates the Relationship Between Cardiorespiratory Fitness and Cognitive Speed in Aging Adults. (2023) (0)
- Intra-individual cognitive variability: An alternative to invasive Alzheimer’s disease biomarkers? (2015) (0)
- Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration (2020) (0)
- ASSOCIATION OF TRAUMATIC BRAIN INJURY, POST-TRAUMATIC STRESS DISORDER AND VASCULAR RISK WITH COGNITIVE FUNCTION IN A VETERAN POPULATION: THE BRAVE STUDY (2019) (0)
- P2-008: Regional gray matter brain volume differences in individuals with a maternal versus paternal family history of Alzheimer's disease (2008) (0)
- IC-P-160 COGNITIVE RESERVE AND HIPPOCAMPAL MICROSTRUCTURAL INTEGRITY IN COGNITIVELY HEALTHY OLDER PEOPLE AND MCI PATIENTS (2018) (0)
- P1-256 The effect of insulin and octreotide on verbal memory and attention in cognitively impaired older adults (2004) (0)
- Assessing the significance of insulin resistance on cerebrospinal fluid Alzheimer's disease biomarkers and memory function in people at risk for Alzheimer’s disease: Findings from the wisconsin adrc impact cohort (2015) (0)
- Impact of sex and APOE E4 on age‐related cerebral blood flow trajectories in cognitively asymptomatic middle‐aged and older adults: A longitudinal study (2020) (0)
- Modifiable risk factors moderate the relationship between amyloid and cognition in midlife (2017) (0)
- Psychological well-being and cognitive aging in Black, Native American, and White Alzheimer’s Disease Research Center participants (2022) (0)
- The relationship between intracranial vascular health and metrics of Alzheimer's disease (2015) (0)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
- F4. Alzheimer’s Disease Biomarkers are Associated With Altered White Matter Microstructure (2018) (0)
- The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults (2023) (0)
- IC-P-029 PATIENT-TAILORED PREDICTIONS OF GRAY MATTER ATROPHY IN ALZHEIMER’S DISEASE BASED ON BASELINE FLORTAUCIPIR AND CONNECTOME-BASED SPREAD (2018) (0)
- Brain insulin signaling and neurodegeneration: IRS‐1 isolated from neuronal enriched extracellular vesicles associates with frontal lobe gray matter volume in cognitively unimpaired adults (2022) (0)
- SEX-BASED DIFFERENCES IN DEPRESSION IN INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT OR DEMENTIA COMPARED TO COGNITIVELY UNIMPAIRED OLDER ADULTS (2019) (0)
- Predicting CSF neurogranin and neurofilament light chain protein levels with a neuropathology‐based APOE genetic risk score (2022) (0)
- Baseline cerebrospinal fluid markers in healthy middle-aged adults predict brain health at three-year follow-up (2011) (0)
- MODERATE INTENSITY PHYSICAL ACTIVITY IS ASSOCIATED WITH CSF BIOMARKERS IN PRECLINICAL ALZHEIMER’S DISEASE (2017) (0)
- THE GUT MICROBIOTA-DERIVED METABOLITE TRIMETHYLAMINE N-OXIDE (TMAO) IS ASSOCIATED WITH REDUCED NEUROIMAGING MEASURES OF CEREBROVASCULAR HEALTH IN COGNITIVELY UNIMPAIRED LATE MIDDLE-AGED ADULTS (2019) (0)
- Fitness, independent of physical activity is associated with cerebral blood flow in adults at risk for Alzheimer’s disease (2019) (0)
- Relationship between CSF biomarkers and language fluency in asymptomatic middle-aged adults at increased risk for Alzheimer's disease: The ESPRIT study (2010) (0)
- Trajectory of clinical symptoms accelerates after 10 years of amyloid (2020) (0)
- Potential Cognitive Benefits of Soy Isoflavones.: 16 (2004) (0)
- Wisconsin Comorbidity Assessment Scale (WCAS): A novel, comprehensive, performance-based assessment scale of geriatric syndromes and medical comorbidities in older cancer patients (2007) (0)
- The Influence of Metabolic Syndrome on Simvastatin Therapy In Asymptomatic Adults at Risk for Alzheimer's Disease: The ESPRIT Study (2010) (0)
- Amyloid status is associated with deficits in connected speech language (2021) (0)
- Assessing the Clinical Meaningfulness of the Alzheimer’s Disease Composite Score (ADCOMS) Tool (2022) (0)
- P1-425 Raloxifene enhances cognitive function for postmenopausal women with Alzheimer's disease (2004) (0)
- POSTEROMEDIAL HYPERACTIVATION DURING EPISODIC RECOGNITION IN MEMORY DECLINERS (2014) (0)
- P-054 Decreased posterior cingulate bold response in healthy middle-aged adults with a parental history of Alzheimer’s disease (2007) (0)
- Incidental Findings from 16,400 Brain MRI Examinations of Research Volunteers (2023) (0)
- LOWER NEURITE DENSITY AND ORIENTATION DISPERSION WITHIN GRAY AND WHITE MATTER IN THE ALZHEIMER’S DISEASE PATHOLOGIC FRAMEWORK (2019) (0)
- Insulin resistance is associated with altered microstructure in the medial temporal lobe and fornix of cognitively healthy ApoE ε4 carriers (2015) (0)
- GenEpi: gene-based epistasis discovery using machine learning (2020) (0)
- Elevated cardiovascular risk is associated with altered myelin content (2015) (0)
- Neuroendocrine and cognitive response from testosterone treatment in men with Alzheimer's disease (2000) (0)
- Relation between blood pressure and cognition in a randomized, placebo-controlled, double-blind pilot study with soy isoflavones: Examination of the healthy user bias (2010) (0)
- An examination of baseline plasma Aβ42/40 and intra‐individual cognitive variability (IICV) associations with longitudinal cognitive change in a Black Cohort: Data from the African Americans Fighting Alzheimer’s in Midlife (AA‐FAIM) study (2022) (0)
- Baseline Characteristics of the Wisconsin Registry for Alzheimer??s Prevention (WRAP) (2006) (0)
- EFFECTIVE CONNECTIVITY WITHIN THE DEFAULT MODE NETWORK IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE (2018) (0)
- Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2020) (0)
- THE RELATIONSHIP BETWEEN CEREBRAL PERFUSION, AGE, AND APOE4 IN MIDDLE-AGED ADULTS AT RISK FOR ALZHEIMER'S DISEASE (2014) (0)
- 3 RATE OF UNDIAGNOSED COGNITIVE IMPAIRMENT IN COMMUNITY SETTINGS: IS THERE A NEED FOR SCREENING? (2007) (0)
- CARDIAC WORKLOAD IS ASSOCIATED WITH CSF BIOMARKERS IN COGNITIVELY NORMAL LATE-MIDDLE-AGED ADULTS AT RISK FOR ALZHEIMER’S DISEASE (2019) (0)
- MODIFIABLE RISK FACTORS MODERATE THE RELATIONSHIP BETWEEN BETA-AMYLOID AND LONGITUDINAL COGNITIVE TRAJECTORIES IN THE WISCONSIN REGISTRY FOR ALZHEIMER’S PREVENTION STUDY (2017) (0)
- COMPARISON OF CEREBROSPINAL FLUID NEUROFILAMENT LIGHT CHAIN PROTEIN AND THREE MRI-BASED MORPHOMETRIC ESTIMATES FOR DEFINING NEURODEGENERATION (N) ACROSS THE ALZHEIMER’S DISEASE CONTINUUM (2019) (0)
- WLS-ILIAD: New Longitudinal Resource for Cognitive and Dementia Data (2021) (0)
- Trajectory of clinical symptoms in relation to amyloid chronicity (2022) (0)
- Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults puncture, blood draw and neuropsychological testing. CSF AD biomarkers (2016) (0)
- Using a common sense model to predict willingness to be screened for mild cognitive impairment in a community sample of African-Americans (2013) (0)
- Fitness Trumps Fatness: An Examination of Cognition and Cerebral Volume (2019) (0)
- The trend of disruption in the functional brain network topology of Alzheimer’s disease (2021) (0)
- REGIONAL DEFICIT IN SLEEPING BRAIN ACTIVITY ASSOCIATED WITH TAU AND AMYLOID PATHOLOGY IN COGNITIVELY HEALTHY MIDDLE-AGED ADULTS (2017) (0)
- Simvastatin maintains white matter integrity in healthy middle‐aged adults with increased risk for Alzheimer’s disease: A secondary analysis of a randomized controlled trial (2020) (0)
- THE STRESS AND RESILIENCE IN DEMENTIA (STRIDE) STUDY: SOCIAL-BIOLOGICAL DIMENSIONS OF ADRD RISK, DISPARITY, AND RESILIENCE (2019) (0)
- ASSOCIATION OF CARDIOVASCULAR RISK FACTORS WITH MICRO- AND MACROVASCULAR CEREBRAL FUNCTION IN WHITES AND AFRICAN AMERICANS (2018) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- Alzheimer disease: Update on diagnosis and treatment (2005) (0)
- EFFECTIVE CONNECTIVITY WITHIN THE LEFT AND RIGHT EXECUTIVE CONTROL NETWORKS IN MCI AND AD (2019) (0)
- Area‐level deprivation is associated with rate of memory decline in late life within a community‐based cohort (2021) (0)
- PATTERNS OF IN-VIVO PRECLINICAL TAU AND AMYLOID BURDEN USING [F-18]THK5351 AND [C-11]PIB (2016) (0)
- AMYLOID DEPOSITION IN THE POSTERIOR CINGULATE IS ASSOCIATED WITH ALTERED MICROSTRUCTURE IN COGNITIVELY ASYMPTOMATIC INDIVIDUALS: FINDINGS FROM THE WRAP STUDY (2016) (0)
- Blood‐brain barrier permeability measured by 7α‐hydroxy‐3‐oxo‐4‐cholestenoic acid in CSF associates with Alzheimer’s pathology biomarkers in cerebrospinal fluid (2020) (0)
- DECREASED CORTICAL NEURITE DENSITY AND ORIENTATION DISPERSION IN ALZHEIMER’S DISEASE DEMENTIA (2019) (0)
- The Aging Imperative-Innovations in Research, Education, and Care in Geriatric Medicine. (2018) (0)
- Cardiorespiratory fitness modifies influence of sleep problems on CSF biomarkers in an at-risk cohort (2019) (0)
- Willingness to be screened for mild cognitive impairment in a community sample of African-Americans: Role of stigma and social support (2013) (0)
- IMPACT OF SIMVASTATIN ON CEREBRAL BLOOD FLOW, PULSATILITY INDEX, AND ALZHEIMER’S DISEASE BIOMARKERS: A CLINICAL TRIAL (2018) (0)
- IMPROVING DEMENTIA OUTCOMES IN INDIAN COUNTRY: THE ONEIDA NATION ALZHEIMER'S DISEASE PROJECT (2019) (0)
- Relation between blood pressure and cognition in a randomized, placebo-controlled, double-blind pilot study with soy isoflavones (2009) (0)
- PATTERNS OF [C-11]PIB AMYLOID BURDEN THAT ARE ASSOCIATED WITH CEREBROSPINAL FLUID AD BIOMARKERS IN PEOPLE AT RISK FOR ALZHEIMER'S DISEASE: FINDINGS FROM THE WRAP STUDY (2014) (0)
- Relationships between psychosocial stress, cerebrospinal fluid markers of Alzheimer’s disease, and cognitive function in middle‐aged and older adults (2022) (0)
- P3-038 High plasma insulin levels provoke increases in central but not peripheral cytokine levels: relationship to CSF and plasma beta amyloid (2004) (0)
- CSF amyloid, tau, and neurodegeneration biomarkers are associated with longitudinal cognitive decline in preclinical AD (2021) (0)
- Predicting Risk for Dementia: Is It Ready for the Clinic? (2019) (0)
- Cardiorespiratory fitness and cognition in persons at risk for Alzheimer's disease (2022) (0)
- P4-007: Parental family history is related to microstructural brain changes in presymptomatic middle-aged and older adults (2008) (0)
- Insulin resistance is associated with altered microstructure in the medial temporal lobe and fornix of cognitively healthy ApoE4 carriers (2015) (0)
- P2-393: Cognitive benefits of hormone therapy use in women matched for cardiovascular risk factors (2008) (0)
- Neurocognition in Menopause and Reproductive Disorders (2019) (0)
- LIFETIME RECREATIONAL PHYSICAL ACTIVITY IS ASSOCIATED WITH CSF AMYLOID IN COGNITIVELY ASYMPTOMATIC ADULTS (2016) (0)
- Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation. (2022) (0)
- MEASURES OF OBESITY AS PREDICTORS OF COGNITIVE FUNCTION IN A COGNITIVELY NORMAL POPULATION (2018) (0)
- INCIDENT DEMENTIA IN NON-HISPANIC AFRICAN AMERICANS AND WHITES WITH MILD COGNITIVE IMPAIRMENT: CAN WE MAKE RACIAL COMPARISONS USING ALZHEIMER’S DISEASE CENTER DATA? (2018) (0)
- The relationship of cerebral perfusion with age and CSF measures in middle-aged adults at risk for Alzheimer's disease (2013) (0)
- Age of amyloid onset, but not amyloid accumulation rate, differs across APOE‐e4 carriers vs. non‐carriers in three cohorts and three methods (2021) (0)
- Gut microbe‐modulated metabolites are longitudinally associated with higher neurodegeneration biomarkers in cerebrospinal fluid (CSF) (2022) (0)
- MICROSTRUCTURAL ALTERATIONS WITH OLDER AGE EVALUATED USING THE NODDI MODEL IN A LARGE GROUP OF COGNITIVELY UNIMPAIRED INDIVIDUALS (2019) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- CEREBROSPINAL FLUID MICROGLIAL MARKERS IN ALZHEIMER'S DISEASE, MCI, AND ASYMPTOMATIC ADULTS (2014) (0)
- Social isolation and cognitive function in middle aged and older adults in the Wisconsin Alzheimer’s Disease Research Center: Implications for the pandemic (2022) (0)
- Hippocampal volumes are associated with cognitive performance in recently menopausal APOE ε4 carriers (2011) (0)
- Cardiorespiratory fitness attenuates adverse influence of poor sleep on CSF biomarkers in an at-risk cohort (2019) (0)
- AN MRI-DERIVED DISEASE MARKER ASSOCIATES WITH CONVERSION TO MCI IN MIDDLE-AGED ADULTS AT RISK FOR AD (2018) (0)
- 4D-FLOW IN THE CEREBRAL ARTERIES PROVIDES UNIQUE INFORMATION ABOUT CEREBROVASCULAR HEALTH BEYOND ISCHEMIC LESION BURDEN AND SIGNIFICANTLY PREDICTS COGNITIVE OUTCOMES (2017) (0)
- Author ' s response to reviews Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk Title : for Alzheimer ' s Disease : a cross-sectional study (2005) (0)
- LESSONS FROM A RESEARCH COLLABORATION WITH THE ONEIDA NATION OF WISCONSIN (2019) (0)
- Findings from a randomized, placebo-control, clinical trial examining the potential cognitive effects of soy isoflavones in patients with Alzheimer's disease (2011) (0)
- EVIDENCE FOR EARLY DETECTION OF CSF BETA-AMYLOID AND TAU AND EFFECT ON LONGITUDINAL COGNITIVE PERFORMANCE IN INDIVIDUALS AT RISK FOR ALZHEIMER’S DISEASE (2017) (0)
- Insulin resistance is related to cognitive decline but not biomarkers of Alzheimer’s pathology in adults without dementia (2020) (0)
- Associations Between Midlife Menopausal Hormone Therapy Use, Incident Diabetes, and Late Life Memory in the Wisconsin Longitudinal Study. (2023) (0)
- GROWING UP ON A FARM AND COGNITIVE FUNCTIONING IN LATER LIFE (2019) (0)
- Participation in cognitively-stimulating activities is associated with brain structure and cognitive function in preclinical Alzheimer’s disease (2014) (0)
- P4-363: A randomized clinical trial of vitamin E and memantine in Alzheimer's disease (2008) (0)
- P2-377 CSF biomarkers correlate with regional brain volume and fMRI activation patterns in middle-aged adults at risk for Alzheimer’s disease (2006) (0)
- Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction (2023) (0)
- What are key factors that promote continued participation in Alzheimer's disease prevention studies? (2011) (0)
- AEROBIC TRAINING IS RELATED TO COGNITIVE HEALTH IN ADULTS AT RISK FOR ALZHEIMER’S DISEASE: RESULTS FROM THE AEROBIC EXERCISE AND COGNITIVE HEALTH (REACH) PILOT STUDY (2018) (0)
- Cardiorespiratory fitness is associated with brain structure, cognition, and mood in a middle-aged cohort at risk for Alzheimer’s disease (2014) (0)
- ASSOCIATION OF CARDIOVASCULAR RISK AND SUBJECTIVE MEMORY COMPLAINTS IN HEALTHY MIDDLE AGED ADULTS (2019) (0)
- Neuroimaging Intracranial arterial four-dimensional flow is associated with metrics of brain health and Alzheimer's disease (2015) (0)
- INSULIN RESISTANCE AND CENTRAL OBESITY IN APOE4 CARRIERS ARE ASSOCIATED WITH INCREASES IN CEREBRAL SPINAL FLUID PHOSPHORYLATED TAU (2014) (0)
- Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease. (2023) (0)
- Neuroinflammation in preclinical Alzheimer’s disease is associated with parahippocampal pathology and memory deficits (2015) (0)
- DECREASED CORTICAL NEURITE DENSITY AND ORIENTATION DISPERSION IN ALZHEIMER’S DISEASE DEMENTIA (2019) (0)
- Review Article Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease (2009) (0)
- The relationship of white matter hyperintensities with perfusion and cognition in middle-aged adults at risk for Alzheimer's disease (2011) (0)
- Diabetes is related to cognition but not plasma amyloid‐β 42/40 in an African American cohort (2022) (0)
- Cardiorespiratory capacity modifies the association between a polygenic risk score and CSF biomarkers in preclinical Alzheimer’s disease (2015) (0)
- NEIGHBORHOOD DISADVANTAGE PREDICTS HIPPOCAMPAL VOLUME AMONG PARTICIPANTS IN THE WISCONSIN REGISTRY FOR ALZHEIMER’S PREVENTION (2018) (0)
- Chronicity of amyloid: Methods for estimating amyloid onset and clinical research applications (2020) (0)
- Overcoming recruitment challenges for brain tissue donation: The University of Wisconsin, Madison Alzheimer's Disease Brain Bank (2009) (0)
- REGIONAL DEFICIT IN SLEEPING BRAIN ACTIVITY ASSOCIATED WITH TAU AND AMYLOID PATHOLOGY IN COGNITIVELY HEALTHY MIDDLE-AGED ADULTS (2017) (0)
- Cardiorespiratory fitness attenuates age-associated aggregation of white matter hyperintensities in an at-risk cohort (2018) (0)
- RELATIONSHIPS BETWEEN P-TAU AND CHANGES IN MYELIN CONTENT AND COGNITIVE PERFORMANCE (2019) (0)
- Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease (2018) (0)
- RELATIONSHIP BETWEEN ALZHEIMER’S DISEASE BIOMARKERS AND CHANGE IN MYELIN AMONG COGNITIVELY UNIMPAIRED ADULTS (2018) (0)
- The relationship of deep white matter hyperintensity lesion size with perfusion and cognition in middle-aged adults at risk for Alzheimer's disease (2012) (0)
- The relationship of deep white matter hyperintensity lesion size with perfusion and cognition in middle-aged adults at risk for Alzheimer's disease (2012) (0)
- 289 Hyperinsulinemia improves memory in Alzheimer's disease (1996) (0)
- INCREASED PLASMA TRIMETHYLAMINE-N-OXIDE (TMAO) IS ASSOCIATED WITH LOWER HIPPOCAMPAL BLOOD FLOW (2018) (0)
- QUANTITATIVE T1 IN ALZHEIMER’S DISEASE (2018) (0)
- IC‐P‐087: WITHDRAWN (2018) (0)
- Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty (2017) (0)
- The effects of gender on the relationship between body mass index and CSF AB42 and tau levels (2005) (0)
- CSF MARKERS OF NEURODEGENERATION ARE ASSOCIATED WITH QUANTITATIVE T1 (2019) (0)
- P 2117 MICRORNAS AS NOVEL BIOMARKERS IN AD : DIFFERENTIAL EXPRESSION IN HIPPOCAMPUS AND IN CELL-FREE CEREBROSPINAL FLUID (2014) (0)
- Gut inflammation associated with age and Alzheimer's disease pathology (2022) (0)
- Cardiorespiratory capacity correlates with cerebral blood flow, white matter hyperintensities, and cognition in preclinical Alzheimer's disease (2015) (0)
- The influence of race on intraprocedural complication and side effect rates of lumbar punctures (2021) (0)
- TAU IMAGING WITH [F-18]MK6240 ACROSS THE AD SPECTRUM: ASSOCIATIONS WITH AMYLOID AND COGNITIVE STATUS (2018) (0)
- Alzheimer’s pathologic change indexed by CSF B‐amyloid42 associates with longitudinal alterations in myelin content (2020) (0)
- LATENT PROFILES DERIVED FROM ATN RELATED CSF BIOMARKERS (2018) (0)
- Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (0)
- Blood pressure moderates insulin-induced memory facilitation in older adults with and without memory impairments (2010) (0)
- Gender differences in cognitive performance and response to simvastatin in adults at risk for Alzheimer's disease: (The ESPRIT Study) (2010) (0)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (0)
- High amyloid load is associated with episodic memory decline and incident mild cognitive impairment in middle-aged adults in the wisconsin registry for Alzheimer’s prevention (WRAP) (2015) (0)
- The relationship between intracranial vascular health and metrics of Alzheimer's disease (2015) (0)
- FOUR-DIMENSIONAL ARTERIAL BLOOD FLOW METRICS IN THE INTERNAL CAROTID ARTERY PREDICT COGNITIVE PERFORMANCE AND ARE ASSOCIATED WITH CSF BIOMARKERS IN PATIENTS WITH MCI (2016) (0)
- P4-351 Effects of hormone therapy on functional MRI activation: Importance of form and mode of administration (2006) (0)
- Quantitative myelin imaging with MPnRAGE‐derived R1 mapping: Applications to Alzheimer’s disease (2022) (0)
- Cognitive effects of estrogen in women with Alzheimer's disease (1999) (0)
- Amyloid duration and entorhinal tau interact to influence cognition in preclinical Alzheimer’s disease (2022) (0)
- P2-064: Attenuated functional connectivity associated with impaired awareness of deficit in amnestic mild cognitive impairment (2008) (0)
- Contrasting alterations between cortical and subcortical myelin across age, AD diagnosis, and amyloid and tau pathology as assessed by quantitative R1 mapping (2020) (0)
- LIFETIME PHYSICAL ACTIVITY IS ASSOCIATED WITH CSF AMYLOID IN COGNITIVELY ASYMPTOMATIC APOE ɛ4+ ADULTS (2017) (0)
- Visual assessment of 11C-PIB PET and 18F-FDG PET for detection of amyloid burden and abnormal metabolism among cognitively normal middle-aged adults with high risks for Alzheimer's disease (2012) (0)
- Neuroendocrine markers of cognition-enhancing efficacy of estrogen in postmenopausal women with Alzheimer's disease (2000) (0)
- CSF sphingolipid levels correlate with CSF beta-amyloid and tau (2013) (0)
- OBSTRUCTIVE SLEEP APNEA IS ASSOCIATED WITH LOWER MEMORY FUNCTION IN MIDDLE-AGED ADULTS (2018) (0)
- P4-012: Increased duration of statin use is associated with better cognitive performance in middle-aged adults: The Wisconsin Registry for Alzheimer's Prevention (WRAP) (2008) (0)
- Relationships between well‐being and cognitive function among Native American, Black, and White participants in the Wisconsin Alzheimer's Disease Research Center (2021) (0)
- THE A/T/N FRAMEWORK IN THE WISCONSIN REGISTRY FOR ALZHEIMER’S PREVENTION: EVIDENCE FROM PET IMAGING (2019) (0)
- AMYLOID BURDEN, CORTICAL THICKNESS, AND COGNITIVE FUNCTION IN THE WISCONSIN REGISTRY FOR ALZHEIMER'S PREVENTION (2014) (0)
- PLASMA A b AND CEREBRAL AND DEPOSITION THE GUT MICROBIOTA-DERIVED METABOLITE TRIMETHYLAMINE N-OXIDE (TMAO) IS ELEVATED IN ALZHEIMER’S (0)
- Bacteroides genus is associated with lower executive function in cognitively unimpaired participants (2022) (0)
- LOWER ARTERIAL BLOOD FLOW AND HIGHER PULSATILITY INDEX ARE ASSOCIATED WITH NEURONAL INJURY (2019) (0)
- LONGEVITY GENE KLOTHO ALTERS APOE4-RELATED CORTICAL THINNING: FINDINGS FROM THE WISCONSIN REGISTRY FOR ALZHEIMER’S PREVENTION (2016) (0)
- Recruiting for Alzheimer's disease Research: A systematic review of recruitment techniques and challenges among NIH-funded ADRCs (2009) (0)
- Impact Of Statin Blood-brain Barrier Permeability On Test Performance In Asymptomatic Middle-aged Adults At Risk For AD: The WRAP Cohort (2009) (0)
- Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease (2018) (0)
- CSF MARKERS OF NEURODEGENERATION ARE ASSOCIATED WITH QUANTITATIVE T1 (2019) (0)
- AN MRI-DERIVED DISEASE MARKER IS ASSOCIATED WITH CONVERSION TO MCI IN MIDDLE-AGED ADULTS AT RISK FOR AD (2018) (0)
- HOW DO WE DEFINE N+? COMPARISON OF DIFFERENT MRI-BASED MORPHOMETRIC ESTIMATES FOR DEFINING NEURODEGENERATION IN CSF AMYLOID-POSITIVE INDIVIDUALS ACROSS THE ALZHEIMER’S DISEASE SPECTRUM (2018) (0)
- Immediate andDelayed Recall 10 ) and executive functioning ( Trail Making Test Part B [ TMT-B ] , 11 Animal Fluency (0)
- CEREBRAL GLUCOSE UPTAKE IN THE CONTEXT OF PERIPHERAL INSULIN (2019) (0)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
- DOES β-AMYLOID BURDEN PREDICT COGNITIVE DECLINE STATUS IN ADULTS AT RISK FOR ALZHEIMER’S DISEASE? (2018) (0)
- Racial Differences in Associations of Cognitive Health Status With Happiness, Helplessness, and Hopelessness Among Older Adults: An Exploratory Study (2022) (0)
- Subjective memory complaints in middle-aged adults with a family history of Alzheimer’s disease (2015) (0)
- HYPOXIA DURING SLEEP IS ASSOCIATED WITH HIPPOCAMPAL VOLUME IN COGNITIVELY UNIMPAIRED ADULTS (2018) (0)
- CEREBRAL GLUCOSE UPTAKE DIFFERS BY LEVEL OF HOMA-IR AND INSULIN SECRETION IN NONDIABETIC ADULTS (2018) (0)
- POSITIVE AFFECT AS A PREDICTOR OF INCIDENT MILD COGNITIVE IMPAIRMENT AND DEMENTIA (2019) (0)
- POOR SLEEP QUALITY IS ASSOCIATED WITH CSF MARKERS OF AMYLOID DEPOSITION IN COGNITIVELY HEALTHY ADULTS AT RISK FOR ALZHEIMER'S DISEASE (2016) (0)
- sentations: P3 P659 P3-101 WITHDRAWN Poster Pre P3-102 APOE-E4 ALLELE STATUS IS ASSOCIATEDWITH FUNCTIONAL LIMITATIONS IN COMMUNITY- DWELLING OLDER ADULTS (2015) (0)
- RELATIONSHIP BETWEEN AORTIC AUGMENTATION INDEX BY RADIAL ARTERY TONOMETRY AND CEREBRAL PULSATILITY INDEX IN INDIVIDUALS AT RISK FOR ALZHEIMER’S DISEASE (2018) (0)
- IC-P-030 The influence of AD family history and ApoE4 on vulnerable brain regions in cognitively normal middle-aged adults (2006) (0)
- Author Correction: FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2022) (0)
- 4D-FLOW IN THE CEREBRAL ARTERIES PROVIDES UNIQUE INFORMATION ABOUT CEREBROVASCULAR HEALTH BEYOND ISCHEMIC LESION BURDEN AND SIGNIFICANTLY PREDICTS COGNITIVE OUTCOMES (2017) (0)
- Unexpected Findings from 8,205 Brain Magnetic Resonance Imaging Examinations of Research Volunteers ≥ 40 years old (2022) (0)
- ASSOCIATION BETWEEN N-ACETYLARGININE AND ALZHEIMER’S DISEASE CSF BIOMARKERS NEUROFILAMENT LIGHT AND YKL-40 (2019) (0)
- Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer’s disease in late-middle-aged adults (2017) (0)
- Insulin Resistance and Apolipoprotein-E Genetype in Alzheimer's Disease (1999) (0)
- The U-ARE Protocol: A Pragmatic Approach to Decisional Capacity Assessment for Clinical Research. (2019) (0)
- COMPARING COGNITIVE BATTERIES: UNIFORM DATA SET 2 (UDS-2) AND UNIFORM DATA SET 3 (UDS-3) IN NON-HISPANIC WHITE PARTICIPANTS AND THOSE FROM UNDERREPRESENTED GROUPS ENROLLED IN THE WISCONSIN ALZHEIMER'S DISEASE RESEARCH CENTER'S CLINICAL CORE (2017) (0)
- Cognitive decline, neural function and amyloid burden in middle-aged adults at risk for Alzheimer's disease: Findings from the Wisconsin Registry for Alzheimer's Prevention (WRAP) (2013) (0)
- PATTERNS OF IN-VIVO PRECLINICAL TAU AND AMYLOID BURDEN USING [F-18]THK5351 AND [C-11]PIB (2016) (0)
- Greater COVID‐19 impact for underrepresented racial and ethnic minority groups: A survey study on the Wisconsin Alzheimer’s Disease Research Center participants (2021) (0)
- RELATIONSHIPS BETWEEN P-TAU AND CHANGES IN MYELIN CONTENT AND COGNITIVE PERFORMANCE (2019) (0)
- AD FAMILY HISTORY MODULATES EFFECTS OF TOMM40 ‘523’ POLY-T ON MTL ATROPHY AND HYPOMETABOLISM IN PRECLINICAL AND AD COHORTS (2017) (0)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (0)
- O4-01-04 BENEFICIAL EFFECTS OF ANGIOTENSIN II RECEPTOR BLOCKERS ON METABOLIC DISORDER-INDUCED COGNITIVE IMPAIRMENT (0)
- Obesity Elevated Insulin and Insulin Resistance are Associated with Altered Myelin in Cognitively Unimpaired Middle-Aged Adults (2019) (0)
- O2-01-04 MINDFULNESS TRAINING: A NOVEL APPROACH TO INTERVENING IN OLDER ADULTS WITH SUBJECTIVE COGNITIVE DECLINE (2014) (0)
- POSTEROMEDIAL HYPERACTIVATION DURING EPISODIC RECOGNITION IN MEMORY DECLINERS (2014) (0)
- DISTINCT COGNITIVE TRAJECTORIES IN LATE MIDDLE-AGE AND THEIR ASSOCIATIONS WITH BRAIN STRUCTURE AND ALZHEIMER'S DISEASE BIOMARKERS: FINDINGS FROM THE WISCONSIN REGISTRY FOR ALZHEIMER’S PREVENTION (2016) (0)
- Abstract 13907: Effects of Simvastatin on Arterial Stiffness are Transient: A Randomized Controlled Trial (2017) (0)
- P1-081 Do subjective memory complaints correspond to neuropsychological deficits? (2004) (0)
- P2-115: Influence of vascular risk factors on cognitive performance in community-dwelling African Americans (2008) (0)
- 077 BEYOND AGS CRITERIA: IDENTIFYING SENIORS AT-RISK FOR FALLS (2010) (0)
- AD‐associated CSF biomolecular changes are attenuated in KL‐VS heterozygotes (2022) (0)
- Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer’s Disease (2018) (0)
- MCI STATUS, AMYLOID AND TAU BIOMARKERS, AND COMPOSITE COGNITIVE IMPAIRMENT SCORES ARE ASSOCIATED WITH COGSTATE PERFORMANCE IN THE WISCONSIN REGISTRY FOR ALZHEIMER'S PREVENTION (2016) (0)
- O4-01-01 The influence of AD family history and APOE4 on vulnerable brain regions in cognitively normal middle-aged adults (2006) (0)
- IC-P-178 OCCUPATIONAL COMPLEXITY, COGNITIVE RESERVE, ANDWHITE MATTER HYPERINTENSITIES: FINDINGS FROM THE WISCONSIN REGISTRY FOR ALZHEIMER’S PREVENTION (2019) (0)
- ASSOCIATION OF CHOLESTEROL AND CHOLESTEROL METABOLISM GENES WITH COGNITIVE FUNCTION IN A POPULATION ENRICHED FOR A PARENTAL HISTORY OF ALZHEIMER’S DISEASE (2017) (0)
- O 104-06 CORRELATION OF MEMORY DYSFUNCTION AND AMYLOID BURDEN IN MILD COGNITIVE IMPAIRMENT (2007) (0)
- PARTICIPATION IN COGNITIVELY-STIMULATING ACTIVITIES IS ASSOCIATED WITH BRAIN STRUCTURE AND COGNITIVE FUNCTION IN PRECLINICAL ALZHEIMER'S DISEASE (2014) (0)
- P3-269 PROGNOSTIC VALUE OF EVENT- RELATED POTENTIALS FOR RATE OF COGNITIVE DECLINE IN PATIENTS WITH MILD ALZHEIMER’S DISEASE (2018) (0)
- A blood-based signature of cerebrospinal fluid Aβ1–42 status (2019) (0)
- Assessing functional disability in individuals with MCI and dementia (2020) (0)
- Liver-Specific Polygenic Risk Score Is Associated with Alzheimer's Disease Diagnosis. (2023) (0)
- CSF metabolites associated with biomarkers of Alzheimer's disease pathology (2022) (0)
- Hormones, Cognition and Dementia: Testosterone therapy and Alzheimer's disease: potential for treatment and prevention in women (2009) (0)
- Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk (2022) (0)
- Cardiorespiratory capacity correlates with cerebral blood flow, white matter hyperintensities, and cognition in preclinical Alzheimer's disease (2015) (0)
- P4-341 Effects of insulin and octreotide on memory in Alzheimer’s disease and healthy aging (2006) (0)
- IC-P1-067: The influence of Alzheimer's disease family history and Apolipoprotein E ϵ4 on task-dependent posterior cingulate activation (2008) (0)
- P2-264 Reduced medial parietal activity in cognitively-healthy middle-aged individuals with a parental history of Alzheimer’s disease (2006) (0)
- P4-350 A COMPARISON OF MULTI-TEST OPERATIONALIZATIONS OF COGNITIVE DECLINE USING LONGITUDINAL NORMS: ASSOCIATIONS WITH PROGRESSION TO COGNITIVE IMPAIRMENTAND AMYLOID STATUS (0)
- Early mild cognitive impairment in the Wisconsin Registry for Alzheimer's Prevention (WRAP) (2012) (0)
- C-13 Sex Differences in Cognitive and Neurobiological Markers of Alzheimer's Disease (2019) (0)
- P2-172 MCI patients with better ravlt learning performance have greater FMRI activation in the anterior hippocampus during an encoding task (2004) (0)
- THE RELATIONSHIP BETWEEN CEREBRAL PERFUSION, AGE, AND APOE4 IN MIDDLE-AGED ADULTS AT RISK FOR ALZHEIMER'S DISEASE (2014) (0)
- MCI STATUS, AMYLOID AND TAU BIOMARKERS, AND COMPOSITE COGNITIVE IMPAIRMENT SCORES ARE ASSOCIATED WITH COGSTATE PERFORMANCE IN THE WISCONSIN REGISTRY FOR ALZHEIMER'S PREVENTION (2016) (0)
- The interaction of amyloid and tau on decreased cortical neurite density in preclinical Alzheimer’s disease (2020) (0)
- FOUR DIMENSIONAL ARTERIAL BLOOD FLOW METRICS IN THE INTERNAL CAROTID ARTERY PREDICT COGNITIVE PERFORMANCE AND ARE ASSOCIATED WITH CSF BIOMARKERS IN PATIENTS WITH MCI (2016) (0)
- OBSTRUCTIVE SLEEP APNEA IS ASSOCIATED WITH LOWER MEMORY FUNCTION IN MIDDLE-AGED ADULTS (2018) (0)
- Posteromedial hyperactivation during episodic recognition among people with memory decline: findings from the WRAP study (2014) (0)
- Assessing the capacity of patients with dementia to provide informed consent to participate in research: How important is memory? (2010) (0)
- P-023 Arterial spin-labeling MR imaging in middle-aged adults at risk for Alzheimer’s disease: Association of clinical measures of global vascular risk with quantitative cerebral perfusion (2007) (0)
- STATISTICAL ALGORITHMS FOR HARMONIZING BIOMARKER DISTRIBUTIONS ACROSS DIFFERENT COHORTS, SITES AND ASSAYS: APPLICATIONS TO CSF MEASUREMENTS (2017) (0)
- P-151 Co-administration of estradiol and cortisol modulates beta-amyloid, IGF activity, and cognitive function for older postmenopausal women (2007) (0)
- TOBACCO EXPOSURE AND CESSATION IS ASSOCIATED WITH INCIDENT DEMENTIA AND NURSING HOME PLACEMENT (2018) (0)
- 16 POTENTIAL COGNITIVE BENEFITS OF SOY ISOFLAVONES. (2004) (0)
- IC-P2-156: Detecting early onset of Alzheimer's disease with MR ASL, FDG PET, PIB PET and O 15 PET: A multi-modal neuroimage approach (2008) (0)
- IC-P-149 DECREASED CORTICAL NEURITE DENSITYAND ORIENTATION DISPERSION IN ALZHEIMER’S DISEASE DEMENTIA (2019) (0)
- IMPLICATIONS OF SLEEP DISPARITIES FOR COGNITIVE TEST PERFORMANCE AMONG AFRICAN AMERICAN AND WHITE OLDER ADULTS: PRELIMINARY EVIDENCE FROM TWO WISCONSIN COHORTS (2019) (0)
- RELATIONSHIP BETWEEN THE RENIN ANGIOTENSIN SYSTEM AND ALZHEIMER'S BIOMARKERS: RESULTS FROM THE EMBARK STUDY (2014) (0)
- P3-034 Cerebrospinal fluid beta-amyloid-42 and tau levels in non-demented middle-aged adults at increased risk of developing Alzheimer's disease (2004) (0)
- White Matter Hyperintensities in Recently Menopausal Women Are Associated with Platelet-Derived Surrogate Markers of Cardiovascular Risk (IN8-1.002) (2013) (0)
- POSTMORTEM CEREBROVASCULAR DISEASE AND WHITE MATTER PALLOR ARE ASSOCIATED WITH LOWER ANTEMORTEM CEREBRAL PERFUSION, INCREASED WHITE MATTER HYPERINTENSITIES, AND POOR LEARNING (2016) (0)
- Testing the Association Between Neighborhood Disadvantage and White Matter Hyperintensities (2022) (0)
- DEMOGRAPHIC FACTORS INFLUENCE PARTICIPATION IN LUMBAR PUNCTURES (2018) (0)
- Relationship of insulin resistance and glucose to tau PET positivity (2021) (0)
- GUT MICROBIAL METABOLITES IN CEREBROSPINAL FLUID ARE ASSOCIATED WITH BIOMARKERS OF ALZHEIMER’S DISEASE PATHOLOGY (2019) (0)
- Longitudinal changes in established and exploratory cerebrospinal fluid biomarkers by PTAU/AΒ42 status in cognitively unimpaired adults (2020) (0)
- C-12 Race and Sex Differences in Cognitive and Neurobiological Markers of Alzheimer's Disease (2019) (0)
- QUANTITATIVE T1 IN ALZHEIMER’S DISEASE (2018) (0)
This paper list is powered by the following services:
Other Resources About Sanjay Asthana
What Schools Are Affiliated With Sanjay Asthana?
Sanjay Asthana is affiliated with the following schools:
